Content area

|
|

Behandling af heparininduceret immunbetinget trombocytopeni med argatroban

Forfatter(e)
Overlæge Jørn Dalsgaard Nielsen & professor Lars Heslet Rigshospitalet, Finsencentret, Hæmatologisk Klinik 4 og Abdominalcentret, Intensiv Terapiklinik
Reference: 
Ugeskr Læger 2009;171(8):610-611
Blad nummer: 
Sidetal: 
610-611
Summary Argatroban treatment of heparin-induced immune-mediated thrombocytopenia Ugeskr Læger 2009;171(8):610-611 Heparin-induced immune-mediated thrombocytopenia (HIT) is a life-threatening complication of heparin treatment. When HIT is clinically suspected, heparin treatment should immediately be replaced with an alternative, fast-acting, anticoagulant agent, and blood tests should be carried out to verify or to exclude the diagnosis. Argatroban has recently been approved for HIT treatment in Denmark. Recommendations for dosing of argatroban in HIT patients with and without comorbities are presented.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Andreas Gothardt Lundh | 02/12
1 Kommentar
af Michael Uldall Steinfath | 01/12
1 Kommentar
af Pedram Kazemi-Esfarjani | 01/12
1 Kommentar
af Bjarne Stigsby | 30/11
2 kommentarer
af Camilla Bang | 29/11
2 kommentarer
af Stine Madsen-Østerbye | 29/11
1 Kommentar
af Kaj Seidelin | 29/11
6 kommentarer
af Pedram Kazemi-Esfarjani | 28/11
2 kommentarer
af Ulf Bern Jensen | 24/11
2 kommentarer
af Bodil Marie Nielsen | 24/11
2 kommentarer